搜尋結果
18 小時前 · Over the last few years, given the increase in the incidence and prevalence of both type 2 diabetes mellitus (T2DM) and heart failure (HF), it became crucial to develop guidelines for the optimal preventive and treatment strategies for individuals facing these coexisting conditions. In patients aged over 65, HF hospitalization stands out as the predominant reason for hospital admissions, with ...
My History with Diabetes and Metformin. Type 2. I want to vent a bit. I was diagnosed last year with an A1C of 11.6 and my blood was like 265. I've used diet and glimepiride to get down to my blood being typically around 110 to 140ish. A big improvement for me.
4 天前 · Thirty-eight Japanese patients with type 2 diabetes who were taking anti-diabetic drugs including pioglitazone + metformin, pioglitazone + alogliptin, or pioglitazone + glimepiride were enrolled. These drugs were switched to an FDC of Metact ® , Liobel ® or Sonias ® , respectively, at equivalent dosage.
4 天前 · Evidence-based interaction details between Glimepiride (brand name(s): Amaryl) and Grapefruit, including interaction severity and how likely the interaction is to occur.
3 天前 · The aqueous solubility and subsequently the bioavailability of glimepiride were improved with the use of water-soluble carriers in the formulation of the solid dispersion. Three distinct carriers (mannitol, polyethylene glycol 6000, and cyclodextrin) with three different drug carrier ratios were employed to generate distinct formulations ( n = 9) of glimepiride solid dispersion (1:1, 1:3, and ...
4 天前 · Interaction Details. Glimepiride is classified as belonging to the following category: Antidiabetes Drugs. Theoretically, taking melatonin with antidiabetes drugs might increase the risk of hypoglycemia. Some clinical research shows that melatonin reduces levels of fasting blood glucose and improves glycemic control.
5 天前 · Assess the impact of glucagon-like peptide (GLP)-1 receptor agonists on body weight. Describe the clinical significance of recently published research in the field of incretin therapeutics. Analyze the current evidence in regard to the possible relationship between the administration of GLP-based therapies and the development of pancreatitis.
